pentetic acid has been researched along with organophosphonates in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolphin, DH; Fritzberg, AR; Lyster, DM | 1 |
| Adzamli, IK; Blau, M | 1 |
| Beaney, RP; Keeling, AA; Vaughan, AT | 1 |
| Richards, P; Steigman, J | 1 |
1 review(s) available for pentetic acid and organophosphonates
| Article | Year |
|---|---|
Chemistry of technetium 99m.
Topics: Bone and Bones; Citrates; Colloids; Diphosphates; Erythrocytes; Gluconates; Isotope Labeling; Kidney; Mannitol; Organophosphonates; Pentetic Acid; Phosphates; Quality Control; Radionuclide Imaging; Serum Albumin; Sulfur; Technetium; Tin | 1974 |
3 other study(ies) available for pentetic acid and organophosphonates
| Article | Year |
|---|---|
Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
Topics: Amidines; Animals; Chlorides; Diphosphates; Hydrazines; Isotope Labeling; Mice; Organophosphonates; Oxidation-Reduction; Pentetic Acid; Rabbits; Radionuclide Imaging; Sulfinic Acids; Technetium; Tin | 1977 |
Phosphonate-modified GdDTPA complexes. I. NMRD study of the solution behavior of new tissue-specific contrast agents.
Topics: Contrast Media; Diphosphonates; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Organophosphonates; Pamidronate; Pentetic Acid | 1991 |
Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
Topics: Animals; Bone and Bones; Leukemia, Experimental; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Pentetic Acid; Tissue Distribution; Yttrium Radioisotopes | 1989 |